DLD Asset Management’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
DLD Asset Management's TTPH Position: Q3 2017 in Review
DLD Asset Management sold out of Tetraphase Pharmaceuticals (TTPH) in Q3 2017, closing a stake of 11,500 shares — an estimated $1.64M sold.
DLD Asset Management first reported a position in TTPH in Q2 2017 and held it in 1 quarter. The position peaked at $1.64M in Q2 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.
- DLD Asset Management reported no remaining Tetraphase Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
- DLD Asset Management sold 11,500 Tetraphase Pharmaceuticals shares in Q3 2017, an estimated $1.64M.
- DLD Asset Management first reported a position in Tetraphase Pharmaceuticals in Q2 2017 and held it in 1 quarter.
- DLD Asset Management's Tetraphase Pharmaceuticals position peaked at $1.64M in Q2 2017.
- 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q3 2017.
Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.